Hillevax, INC Form 4 insider transactions

Frazier Life Sciences X, L.P. reports the acquisition and disposition of HilleVax, Inc. common stock on April 4, 2024.

Director Aditya Kohli of HilleVax, Inc. executed sales of common stock between April 3rd and April 5th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

HilleVax's Chief Operating Officer, Sean McLoughlin, purchased 1,250 shares of the company's common stock at a price of $16.98 per share on March 28, 2024.

Director Aditya Kohli of HilleVax, Inc. executed sales of common stock between March 18 and March 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Aditya Kohli of HilleVax, Inc. executed sales of common stock between March 6 and March 8, 2024, under a pre-arranged Rule 10b5-1 trading plan.